In a 2012 open study, significant cognitive deterioration was observed among 70% of patients at 3 months, lasting 12 months in about 20% of patients with Topamax intake. It's clear that temporary brain damage can be caused. However, its permanency may depend on other factors such as dosage and continuous use.